Praxis Precision Medicines, Inc.

PRAX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Market Cap$1,378,107$146,921$109,710$836,345
- Cash$215,372$81,300$61,615$138,704
+ Debt$1,369$2,495$4,505$4,311
Enterprise Value$1,164,104$68,116$52,600$701,952
Revenue$8,553$2,447$0$0
% Growth249.5%
Gross Profit-$143,860-$84,319-$154,440$0
% Margin-1,682%-3,445.8%
EBITDA-$199,807-$125,941-$213,567-$167,150
% Margin-2,336.1%-5,146.8%
Net Income-$182,819-$123,277-$214,029-$167,061
% Margin-2,137.5%-5,037.9%
EPS Diluted-10.21-18.69-69.33-58.96
% Growth45.4%73%-17.6%
Operating Cash Flow-$131,757-$111,136-$185,043-$124,554
Capital Expenditures$0-$50-$444-$1,050
Free Cash Flow-$131,757-$111,186-$185,487-$125,604
Praxis Precision Medicines, Inc. (PRAX) Financial Statements & Key Stats | AlphaPilot